Lg Cwd
Need Help

Submit your question to our team of health care professionals.

Current Question

See what's on the mind of the community right now.

Meet the Team

Learn more about our world-renowned team.

DTeam Archives

Review the entire archive according to the date it was posted.

March 9, 2005

Blood Tests and Insulin Injections, Other

Question from Columbus, Ohio, USA:

How do we prevent lipoatrophy? My daughter has had type 1 diabetes for eight years. We rotate her shots regularly, injecting the shots one inch apart until the particular body part has been totally used. We try to stay away from each body part for four weeks before using it again. We give injections in her arms, stomach, legs, hips, lower and upper buttocks. When reading feedback from articles doctors have written pertaining to lipoatrophy, we are finding claims to the fact that they believe lipoatrophy is occurring because patients aren't rotating enough and are using the same sites too often before rotation. This is not true in our case and lipoatrophy has occurred in every site used throughout our daughter's body. We are running out of areas to give injections due to lack of fat tissue. What do we do? We are desperate for answers. It seems as though using the pump is not an option since we have read testimonials from patients who are experiencing lipoatrophy from using the pump as well.


You might wish to review a previous “Ask the Diabetes Team” question on the same subject.

I presume you do, in fact, mean lipoatrophy, whereby there is an “indenting” of the subcutaneous fat tissue around injection sites. Perhaps a bit more commonly, we see lipohypertrophy, whereby the oft used injection site gets thicker and harder. Lipoatrophy has become so less common with the use of human insulins and newer insulin analogues and even with insulin pumping.

If site rotation and changing insulins and injection systems has not been successful, there are anecdotal reports about the use of a small amount glucocorticoids mixed into the insulin. This usually has involved the use of dexamethasone. I have not seen anything formally published about this, but recently was able to review a published report from 1977 (Use of dexamethasone in treatment of insulin lipoatrophy) involving a handful of patients, discussing the use of dexamethasone at a concentration of 4 micrograms per unit of insulin mixed into the insulin vial.

You should talk to your child’s diabetes team physician.